Sponsor:
St. Vincent's Medical Center
Code:
NCT00926718
Conditions
Laryngoscopy
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
remifentanil infusion
rocuronium dose + remifentanil infusion
rocuronium dose + remifentanil infusion
remifentanil infusion
rocuronium dose + remifentanil infusion
Brief summary:
Conditions
Laryngoscopy
Study ID
NCT00926718
Start date
Jun, 2009
Status verified date
Jun, 2009
Primary completion date
Jun, 2010
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
80 participants
Anticipated
Allocation
Randomized
Intervention Model
Single group
Primary purpose
Basic Science
Arms
experimental: Dose 1a
experimental: Dose 2a
experimental: Dose 3a
experimental: Dose 1b
experimental: Dose 2b
experimental: Dose 3b
Interventions
remifentanil infusion
rocuronium dose + remifentanil infusion
rocuronium dose + remifentanil infusion
remifentanil infusion
rocuronium dose + remifentanil infusion
rocuronium dose + remifentanil infusion
Primary outcome measure
Central contacts
Locations
Saint Vincent Catholic Medical Centers
Recruiting
New York, New York, United States, 10011
Contacts
Principal Investigator:
Donald Mathews, MD
Sponsor
St. Vincent's Medical Center
Last update posted
Jun 23, 2009
Last verified
Jun, 2009
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by St. Vincent's Medical Center on 2009-06-23.